{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:47:02Z","timestamp":1761562022030},"reference-count":9,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T00:00:00Z","timestamp":1441670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2016,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Regarding appropriate timings of discontinuation and resumption of biologics for psoriasis patients before and after elective surgeries, an international consensus has yet to be reached. The Japanese Dermatological Association of Guideline and Safety Manual for the use of Biologic Agents in Psoriasis 2013 states that infliximab (<jats:styled-content style=\"fixed-case\">IFX<\/jats:styled-content>) and adalimumab (<jats:styled-content style=\"fixed-case\">ADA<\/jats:styled-content>) should be withheld at least 4 and 2\u00a0weeks, respectively, before surgery and can be restarted as neither postoperative infection nor delayed wound healing is recognized. We experienced three generalized pustular psoriasis (<jats:styled-content style=\"fixed-case\">GPP<\/jats:styled-content>) patients and one plaque\u2010type psoriasis patient undergoing surgeries during tumor necrosis factor (<jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>)\u2010\u03b1 blocker therapy. Three <jats:styled-content style=\"fixed-case\">GPP<\/jats:styled-content> cases experienced uneventful post\u2010surgical course. One psoriasis vulgaris patient on <jats:styled-content style=\"fixed-case\">IFX<\/jats:styled-content> had a wound healing delay with deterioration of psoriatic plaques which was restored by restarting <jats:styled-content style=\"fixed-case\">IFX<\/jats:styled-content>. The timing of suspension and resumption of <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\u2010\u03b1 blockers in all cases were determined following the Japanese guideline.<\/jats:p>","DOI":"10.1111\/1346-8138.13047","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T12:23:06Z","timestamp":1441714986000},"page":"190-193","source":"Crossref","is-referenced-by-count":9,"title":["Perioperative management of tumor necrosis factor\u2010alpha blocker\u2010treated psoriatic patients: Case reports and review"],"prefix":"10.1111","volume":"43","author":[{"given":"Hiroshi","family":"Kawakami","sequence":"first","affiliation":[{"name":"Department of Dermatology Tokyo Medical University Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Dermatology Tokyo Medical University Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namiko","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Dermatology Tokyo Medical University Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youich","family":"Katori","sequence":"additional","affiliation":[{"name":"Department of Orthopedics Tokyo Medical University Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousuke","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery Tokyo Medical University Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoji","family":"Tsuboi","sequence":"additional","affiliation":[{"name":"Department of Dermatology Tokyo Medical University Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Okubo","sequence":"additional","affiliation":[{"name":"Department of Dermatology Tokyo Medical University Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,9,8]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.1410"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09505.x"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12239"},{"key":"e_1_2_5_5_1","first-page":"430","article-title":"Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers","volume":"25","author":"Ruyssen\u2010Witrand A","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_5_6_1","first-page":"689","article-title":"Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti\u2010tumor necrosis factor: a large retrospective study","volume":"34","author":"Broader AA","year":"2007","journal-title":"J Rheumatol"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-008-0630-8"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.3.214"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21641"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2012.01548.x"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1346-8138.13047","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1346-8138.13047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T09:14:25Z","timestamp":1695546865000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1346-8138.13047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,8]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.1111\/1346-8138.13047"],"URL":"https:\/\/doi.org\/10.1111\/1346-8138.13047","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,8]]}}}